Titre : Multirésistance des champignons aux médicaments

Multirésistance des champignons aux médicaments : Questions médicales fréquentes

Termes MeSH sélectionnés :

Microbial Sensitivity Tests

Questions fréquentes et termes MeSH associés

Général 1

#1

Erreur lors de la génération.

Veuillez réessayer ultérieurement.
Drug Resistance, Multiple, Fungal
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Multirésistance des champignons aux médicaments : Questions médicales les plus fréquentes", "headline": "Multirésistance des champignons aux médicaments : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Multirésistance des champignons aux médicaments : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-19", "dateModified": "2026-08-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Multirésistance des champignons aux médicaments" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Multirésistance aux médicaments", "url": "https://questionsmedicales.fr/mesh/D018432", "about": { "@type": "MedicalCondition", "name": "Multirésistance aux médicaments", "code": { "@type": "MedicalCode", "code": "D018432", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G07.690.773.984.300" } } }, "about": { "@type": "MedicalCondition", "name": "Multirésistance des champignons aux médicaments", "alternateName": "Drug Resistance, Multiple, Fungal", "code": { "@type": "MedicalCode", "code": "D026141", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jinxing Song", "url": "https://questionsmedicales.fr/author/Jinxing%20Song", "affiliation": { "@type": "Organization", "name": "The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Science, Jiangsu Normal University, Xuzhou, PR China." } }, { "@type": "Person", "name": "Rongpeng Li", "url": "https://questionsmedicales.fr/author/Rongpeng%20Li", "affiliation": { "@type": "Organization", "name": "The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Science, Jiangsu Normal University, Xuzhou, PR China." } }, { "@type": "Person", "name": "Amir Arastehfar", "url": "https://questionsmedicales.fr/author/Amir%20Arastehfar", "affiliation": { "@type": "Organization", "name": "Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA." } }, { "@type": "Person", "name": "Cornelia Lass-Flörl", "url": "https://questionsmedicales.fr/author/Cornelia%20Lass-Fl%C3%B6rl", "affiliation": { "@type": "Organization", "name": "Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria." } }, { "@type": "Person", "name": "Farnaz Daneshnia", "url": "https://questionsmedicales.fr/author/Farnaz%20Daneshnia", "affiliation": { "@type": "Organization", "name": "Westerdijk Fungal Biodiversity Institute, 3584 CT Utrecht, The Netherlands." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Direct Microbial Identification using An Automated Microbial Identification System to Facilitate the EUCAST RAST Method Without Mass Spectrometry.", "datePublished": "2024-05-24", "url": "https://questionsmedicales.fr/article/38856199", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3791/66588" } }, { "@type": "ScholarlyArticle", "name": "Microbial keratitis in Southern Malawi: a microbiological pilot study.", "datePublished": "2024-04-22", "url": "https://questionsmedicales.fr/article/38653537", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjophth-2024-001682" } }, { "@type": "ScholarlyArticle", "name": "A simple and sensitive test for", "datePublished": "2024-06-18", "url": "https://questionsmedicales.fr/article/38888304", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/jcm.00525-24" } }, { "@type": "ScholarlyArticle", "name": "The Controversial Effect of Antibiotics on Methicillin-Sensitive", "datePublished": "2023-11-14", "url": "https://questionsmedicales.fr/article/38003500", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms242216308" } }, { "@type": "ScholarlyArticle", "name": "Mentha longifolia assisted nanostructures: An approach to obliterate microbial biofilms.", "datePublished": "2024-07-10", "url": "https://questionsmedicales.fr/article/38985793", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0303521" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques", "item": "https://questionsmedicales.fr/mesh/D010829" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes pharmacologiques et toxicologiques", "item": "https://questionsmedicales.fr/mesh/D002620" }, { "@type": "ListItem", "position": 4, "name": "Phénomènes pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D000069437" }, { "@type": "ListItem", "position": 5, "name": "Résistance aux substances", "item": "https://questionsmedicales.fr/mesh/D004351" }, { "@type": "ListItem", "position": 6, "name": "Multirésistance aux médicaments", "item": "https://questionsmedicales.fr/mesh/D018432" }, { "@type": "ListItem", "position": 7, "name": "Multirésistance des champignons aux médicaments", "item": "https://questionsmedicales.fr/mesh/D026141" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Multirésistance des champignons aux médicaments - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Multirésistance des champignons aux médicaments", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-08-25", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Multirésistance des champignons aux médicaments", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D026141?mesh_terms=Microbial+Sensitivity+Tests#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 07/08/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Jinxing Song

2 publications dans cette catégorie

Affiliations :
  • The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Science, Jiangsu Normal University, Xuzhou, PR China.
Publications dans "Multirésistance des champignons aux médicaments" :

Rongpeng Li

2 publications dans cette catégorie

Affiliations :
  • The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province and School of Life Science, Jiangsu Normal University, Xuzhou, PR China.
Publications dans "Multirésistance des champignons aux médicaments" :

Amir Arastehfar

2 publications dans cette catégorie

Affiliations :
  • Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA.
Publications dans "Multirésistance des champignons aux médicaments" :

Cornelia Lass-Flörl

2 publications dans cette catégorie

Affiliations :
  • Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Publications dans "Multirésistance des champignons aux médicaments" :

Farnaz Daneshnia

2 publications dans cette catégorie

Affiliations :
  • Westerdijk Fungal Biodiversity Institute, 3584 CT Utrecht, The Netherlands.
Publications dans "Multirésistance des champignons aux médicaments" :

Macit Ilkit

2 publications dans cette catégorie

Affiliations :
  • Division of Mycology, University of Çukurova, 01330 Adana, Turkey.
Publications dans "Multirésistance des champignons aux médicaments" :

David S Perlin

2 publications dans cette catégorie

Affiliations :
  • Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA.
Publications dans "Multirésistance des champignons aux médicaments" :

Miquel Àngel Schikora-Tamarit

2 publications dans cette catégorie

Affiliations :
  • Department of Life Sciences, Barcelona Supercomputing Centre (BSC-CNS), Barcelona, Spain.
  • Department of Mechanisms of Disease, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Publications dans "Multirésistance des champignons aux médicaments" :

Toni Gabaldón

2 publications dans cette catégorie

Affiliations :
  • Department of Life Sciences, Barcelona Supercomputing Centre (BSC-CNS), Barcelona, Spain.
  • Department of Mechanisms of Disease, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
  • Department of CIBERinfect, Centro Investigación Biomédica En Red de Enfermedades Infecciosas, Barcelona, Spain.
Publications dans "Multirésistance des champignons aux médicaments" :

Chunyan Sun

2 publications dans cette catégorie

Affiliations :
  • Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, China.
Publications dans "Multirésistance des champignons aux médicaments" :

Yu Hu

2 publications dans cette catégorie

Affiliations :
  • Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, Wuhan, China.
Publications dans "Multirésistance des champignons aux médicaments" :

Pablo D Jimenez Castro

2 publications dans cette catégorie

Affiliations :
  • Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, 30602, USA; Grupo de Parasitología Veterinaria, Universidad Nacional de Colombia, Colombia. Electronic address: pdj38559@uga.edu.
Publications dans "Multirésistance des champignons aux médicaments" :

John S Gilleard

2 publications dans cette catégorie

Affiliations :
  • Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Host-Parasite Interactions Program, University of Calgary, Alberta, Canada.
Publications dans "Multirésistance des champignons aux médicaments" :

Ray M Kaplan

2 publications dans cette catégorie

Affiliations :
  • Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, 30602, USA.
Publications dans "Multirésistance des champignons aux médicaments" :

Omar Faruq

2 publications dans cette catégorie

Affiliations :
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Laboratory Medicine Program, Department of Laboratory Hematology, University Health Network, Toronto, ON M5G 2C4, Canada.
Publications dans "Multirésistance des champignons aux médicaments" :

Eldad Zacksenhaus

2 publications dans cette catégorie

Affiliations :
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2C4, Canada.
Publications dans "Multirésistance des champignons aux médicaments" :

Hong Chang

2 publications dans cette catégorie

Affiliations :
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Laboratory Medicine Program, Department of Laboratory Hematology, University Health Network, Toronto, ON M5G 2C4, Canada.
  • Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2C4, Canada.
Publications dans "Multirésistance des champignons aux médicaments" :

Paloma Osset-Trénor

1 publication dans cette catégorie

Affiliations :
  • Department of Biotechnology, Instituto de Biología Molecular y Celular de Plantas IBMCP, Universidad Politécnica de Valencia, 46022 Valencia, Spain.
Publications dans "Multirésistance des champignons aux médicaments" :

Amparo Pascual-Ahuir

1 publication dans cette catégorie

Affiliations :
  • Department of Biotechnology, Instituto de Biología Molecular y Celular de Plantas IBMCP, Universidad Politécnica de Valencia, 46022 Valencia, Spain.
Publications dans "Multirésistance des champignons aux médicaments" :

Markus Proft

1 publication dans cette catégorie

Affiliations :
  • Department of Molecular and Cellular Pathology and Therapy, Instituto de Biomedicina de Valencia IBV-CSIC, Consejo Superior de Investigaciones Científicas CSIC, 46010 Valencia, Spain.
Publications dans "Multirésistance des champignons aux médicaments" :

Sources (10000 au total)

Microbial keratitis in Southern Malawi: a microbiological pilot study.

Microbial keratitis (MK) is a significant cause of blindness in sub-Saharan Africa. We investigated the feasibility of using a novel corneal impression membrane (CIM) for obtaining and processing samp... Samples were collected from patients presenting with suspected MK using a 12 mm diameter polytetrafluoroethylene CIM disc. Samples were processed using culture and PCR for... 71 eyes of 71 patients were included. The overall CIM isolation rate was 81.7% (58 positive samples from 71 participants). 69 (81.2%) of isolates were Gram-positive cocci. Coagulase-negative... In a resource-poor setting, a CIM can be used to safely sample the cornea in patients presenting with suspected MK, enabling identification of causative microorganisms by culture and PCR. Although the...

The Antifungal Activities of Syzygium aromaticum and Alpinia purpurata Extracts Against Candida krusei: Bioactivity Tests, Molecular Modeling, and Toxicity Tests.

Candida krusei is the cause of the fungal infection candidiasis, which has a high mortality rate. Intrinsic resistance to fluconazole can cause the failure of Krusei candidiasis treatment. Therefore, ... This study aims to explore the active compounds Syzygium aromaticum and Alpinia purpurata as treatments against Candida krusei through bioactivity tests, molecular modeling, and toxicity tests.... Determination of antifungal activity with the agar well diffusion and microbroth dilution method. Molecular modeling was conducted using the following software: Marvin Sketch, LigandScout 4.4.5, AutoD... Bioactivity test results of the two natural extracts against C. krusei ATCC 6258, it was found that the S. aromaticum and A. purpurata extracts have MIC50 values of 0.031 μg/mL and 1.435x105 μg/mL. Th... S. aromaticum and A. purpurata extracts have been proven to be alternative solutions for treating Candida krusei resistance....

Isoniazid resistance in Rifampicin sensitive pulmonary tuberculosis in children and adolescents.

Isoniazid (INH) and Rifampicin (RIF) are two crucial drugs used in antitubercular therapy. INH is known for its potent bactericidal effects and has a relatively higher prevalence of resistance compare... Seventy-five newly diagnosed RIF sensitive PTB cases up to 18 years of age were enrolled. Retreatment cases were excluded. Sputum/gastric aspirate sample of these patients were sent for culture in Myc... INH, EMB and STR resistance among RIF sensitive PTB cases was found to be 5.7%, 0% and 0.7% respectively. RIF resistance detected by CBNAAT was found to be 8.4%.... Detection of INH resistance is as important as detecting RIF resistance as prevalence of INH resistance in RIF sensitive PTB among children and adolescents up to 18 years is around 6%....